Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion type Assertion NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_head.
- NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion description "[Epidermal growth factor receptor 2 (ErbB2) overexpression is common in DCIS, as is disruption of the retinoblastoma tumor suppressor (RB) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_provenance.
- NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion evidence source_evidence_literature NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_provenance.
- NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion SIO_000772 24121271 NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_provenance.
- NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion wasDerivedFrom befree-2016 NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_provenance.
- NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_assertion wasGeneratedBy ECO_0000203 NP1118643.RAi_tPGfl-3qY2sJdhplN1JylpZzv9U9bsRtm6bd6VEjE130_provenance.